A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease

Roy W Jones, Hilkka Soininen, Klaus Hager, Dag Aarsland, Peter Passmore, Anita Murthy, Richard Zhang, Ranbir Bahra

Research output: Contribution to journalArticlepeer-review

93 Citations (Scopus)

Abstract

To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL).
Original languageEnglish
Pages (from-to)58-67
Number of pages10
JournalInternational Journal of Geriatric Psychiatry
Volume19
Issue number1
DOIs
Publication statusPublished - Jan 2004

Bibliographical note

Unrecognised author: 'for the DONGAL Study Group'

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease'. Together they form a unique fingerprint.

Cite this